Literature DB >> 14063471

METHYSERGIDE FOR PREVENTION OF HEADACHE; EXPERIENCE IN FIVE HUNDRED PATIENTS OVER THREE YEARS.

J R GRAHAM.   

Abstract

Entities:  

Keywords:  ERGOT ALKALOIDS; GERIATRICS; HEADACHE; METHYSERGIDE; MIGRAINE; SEROTONIN INHIBITORS; TOXICOLOGIC REPORT

Mesh:

Substances:

Year:  1964        PMID: 14063471     DOI: 10.1056/NEJM196401092700202

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  28 in total

1.  Prophylaxis of vascular headaches.

Authors:  J C Ramseyer
Journal:  Calif Med       Date:  1971-09

2.  Development of heart valve lesions during methysergide therapy.

Authors:  K A Misch
Journal:  Br Med J       Date:  1974-05-18

3.  Retroperitoneal fibrosis.

Authors:  S C Thorson
Journal:  Can Med Assoc J       Date:  1973-04-21       Impact factor: 8.262

4.  Combined mediastinal and retroperitoneal fibrosis.

Authors:  H W Salmon
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

5.  Retroperitoneal fibrosis.

Authors:  J C Ross
Journal:  Proc R Soc Med       Date:  1968-02

6.  The pathology of idiopathic retroperitoneal fibrosis.

Authors:  M J Mitchinson
Journal:  J Clin Pathol       Date:  1970-11       Impact factor: 3.411

7.  Drug-induced localized systemic scleroses.

Authors:  J R Graham
Journal:  Trans Am Clin Climatol Assoc       Date:  1981

Review 8.  Vascular headache.

Authors:  K L Kumar; T G Cooney
Journal:  J Gen Intern Med       Date:  1988 Jul-Aug       Impact factor: 5.128

9.  Bilateral recurrent orbital inflammation associated with retroperitoneal fibrosclerosis.

Authors:  A A Schonder; R C Clift; J W Brophy; L W Dane
Journal:  Br J Ophthalmol       Date:  1985-10       Impact factor: 4.638

10.  Effects of ergotamine and methysergide on blood platelet aggregation responses of migrainous subjects.

Authors:  B P Hilton; K J Zilkha
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-05       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.